awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q37346737-3AAC2924-12F0-4D96-A52F-58B8864A58CF
Q37346737-3AAC2924-12F0-4D96-A52F-58B8864A58CF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37346737-3AAC2924-12F0-4D96-A52F-58B8864A58CF
Clinically relevant reductions in HbA1c without hypoglycaemia: results across four studies of saxagliptin.
P2860
Q37346737-3AAC2924-12F0-4D96-A52F-58B8864A58CF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37346737-3AAC2924-12F0-4D96-A52F-58B8864A58CF
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a63a41d54bce720917db6f481d30172b779aaf6f
P2860
Saxagliptin added to a thiazolidinedione improves glycemic control in patients with type 2 diabetes and inadequate control on thiazolidinedione alone.